Myriad Genetics Faces Cost Restructuring As UnitedHealthcare Ends GeneSight Coverage ...
UnitedHealthcare will stop covering Myriad Genetics' GeneSight test in 2025, impacting $45 million in revenue. Myriad ...
GlobalData on MSN12 天
FDA grants 510(k) clearance to Targeted Genomics’ GlutenID test
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...
Field & Stream26 天
Mallard DNA Test Shows Farm Genetics
I received a pedigree certificate that broke down my opening day greenhead’s genetics. Turns out that ... are truly wild birds with a simple DNA test. Here's how. If you haven’t been keeping ...
manilatimes2 个月
NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an ...
SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic ...